Sensorion SA (EPA:ALSEN)
France · Delayed Price · Currency is EUR 0.2570
-0.0030 (-1.15%)
Jul 14, 2026, 9:00 AM CET
Sensorion Market Cap
Sensorion has a market cap or net worth of €133.83 million as of July 13, 2026. Its market cap has increased by 47.47% in one year.
Market Cap
133.83M
Enterprise Value
87.60M
Revenue
5.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.26
Market Cap Chart
Since April 21, 2015, Sensorion's market cap has increased from 20.46M to 133.83M, an increase of 554.21%. That is a compound annual growth rate of 18.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 133.83M | 32.17% |
| Dec 31, 2025 | 101.25M | -47.00% |
| Dec 31, 2024 | 191.03M | 137.65% |
| Dec 29, 2023 | 80.38M | 171.97% |
| Dec 30, 2022 | 29.56M | -80.74% |
| Dec 31, 2021 | 153.45M | 33.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 413.24M |
| Valerio Therapeutics Société anonyme | 224.75M |
| Transgene | 207.33M |
| Cellectis | 188.04M |
| Innate Pharma | 147.69M |
| OSE Immunotherapeutics | 78.13M |
| Adocia | 73.18M |
| ABIONYX Pharma | 65.36M |